RecruitingPhase 3NCT06545526

Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis

Studying Familial adenomatous polyposis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Yonsei University
Intervention
celecoxib monotherapy(drug)
Enrollment
28 enrolled
Eligibility
20-55 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06545526 on ClinicalTrials.gov

Other trials for Familial adenomatous polyposis

Additional recruiting or active studies for the same condition.

See all trials for Familial adenomatous polyposis

← Back to all trials